FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used in protection of organism against mutagenic impact of heavy metals in experiment. Method includes introduction into organism of medication "Melaxen" in dose from 5.25·10-7 mg to 21.0·10-7 mg per 100 g of live weight as antimutagenic substance daily during 3-7 days before sleeping at cadmium background.
EFFECT: application of invention makes it possible to extend arsenal of means for reduction of mutagenic effect of cadmium.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING ANTIMUTAGENIC PRODUCT | 2014 |
|
RU2590976C2 |
METHOD OF ACTION ON BODY BY ANTIMUTAGENIC AGENT | 2010 |
|
RU2449780C1 |
METHOD FOR REDUCTION OF MUTAGENOUS IMPACT ON ORGANISM | 2016 |
|
RU2643581C1 |
METHOD OF ANTI-MUTAGENIC ACTION ON BODY | 1999 |
|
RU2145869C1 |
METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 |
|
RU2261704C2 |
AGENT FOR REDUCING MUTAGENIC ACTION OF LEAD ACETATE IN BODY | 2014 |
|
RU2584347C2 |
METHOD OF MODELING LOADED METABOLISM WITH COMBINED SUBCHRONIC EXPOSURE TO HEAVY METALS | 2022 |
|
RU2798991C1 |
METHOD OF BULL-CALVES FEED IN ECOLOGICALLY CONTAMINATED AND POLLUTED LANDS | 2009 |
|
RU2402206C1 |
METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
PREPARATION OF ANTIMUTAGENIC ACTIVITY | 2004 |
|
RU2277417C1 |
Authors
Dates
2012-01-20—Published
2010-05-31—Filed